ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,068,181 | -89.7% | 568,182 | -80.0% | 0.12% | -83.7% |
| Q2 2023 | $10,369,314 | +533.7% | 2,840,908 | -0.0% | 0.72% | +528.1% |
| Q1 2023 | $1,636,364 | +159857.4% | 2,840,909 | 0.0% | 0.11% | -3.4% |
| Q4 2022 | $1,023 | -99.9% | 2,840,909 | 0.0% | 0.12% | -37.2% |
| Q3 2022 | $1,701,000 | +21.0% | 2,840,909 | 0.0% | 0.19% | +33.3% |
| Q2 2022 | $1,406,000 | -45.0% | 2,840,909 | 0.0% | 0.14% | -19.9% |
| Q1 2022 | $2,556,000 | -19.7% | 2,840,909 | 0.0% | 0.18% | -8.3% |
| Q4 2021 | $3,182,000 | -37.1% | 2,840,909 | 0.0% | 0.19% | -15.4% |
| Q3 2021 | $5,057,000 | -46.1% | 2,840,909 | 0.0% | 0.23% | -44.1% |
| Q2 2021 | $9,375,000 | -1.5% | 2,840,909 | 0.0% | 0.41% | +21.6% |
| Q1 2021 | $9,517,000 | – | 2,840,909 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |